OOIR: Observatory of International Research

Papers

(The TQCC of Rheumatic Disease Clinics of North America is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Pediatric Rheumatology Comes of Age: Part II	93
Lessons from Cardiac and Vascular Biopsies from Patients with and without Inflammatory Rheumatic Diseases	69
Implementation Science in Pediatric Rheumatology: A Path to Health Equity	49
Contents	37
Copyright	36
Kawasaki Disease and Multisystem Inflammatory Syndrome in Children	28
Advancing Gastrointestinal Microbiota Research in Systemic Sclerosis	27
Immune Checkpoint Inhibitor-induced Inflammatory Arthritis	26
Osteoarthritis Treatment Guidelines from Six Professional Societies	24
Molecular Pathways in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis	24
Forthcoming Issues	21
Immune Checkpoint Inhibitor-induced Polymyalgia Rheumatica	21
Copyright	21
Exploring the Mucosal Immune Response in Axial Spondyloarthritis Through Immunoglobulin A-Coated Microbiota	20
COPA Syndrome from Diagnosis to Treatment	19
Impact of Non-steroidal Anti-inflammatory Drugs, Glucocorticoids, and Disease-Modifying Anti-Rheumatic Drugs on Cancer Response to Immune Checkpoint Inhibitor Therapy	19
Contributors	17
Venous Thromboembolism in the Inflammatory Rheumatic Diseases	16
Taxonomy of Quality of Care Indicators	16
Lessons Learned from the COVID-19 Pandemic in Rheumatology	15
Newer Immunosuppressants for Rheumatologic Disease	14
The Short and Long of COVID-19	14
Contents	14
T Cells in Systemic Lupus Erythematosus	14
B Cells in Systemic Lupus Erythematosus	14

Imaging Challenges and Developments in Large-vessel Vasculitis	14
Vaccinations in Patients with Rheumatic Disease	13
Contents	12
Multisystem Inflammatory Syndrome in Children and Kawasaki Disease	12
It Takes Oysters to Generate Pearls	12
Copyright	11
Primary Cardiac Involvement in Systemic Sclerosis	11
Expanding the Treatment Team	11
Pulmonary Hypertension Associated with Connective Tissue Disease	11
De novo Connective Tissue Disorders as Immune-related Adverse Events	10
Uveitis in Children and Adolescents	10
The Utility of Laboratory Investigations for the Assessment and Management of Rheumatic Immune Related Adverse Events	10
Managing Immunosuppression in Vasculitis Patients in Times of Coronavirus Disease 2019	9
Rheumatology Pearls for the Primary Care Physician	9
Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease	9
Scleroderma: Best Approaches to Patient Care	9
Assessing Patient-Reported Outcomes in Pediatric Rheumatic Diseases	8
COVID-19 and Rheumatology	8
Systemic Lupus Erythematosus Classification and Diagnosis	8
Mimickers of Immune Checkpoint Inhibitor-induced Inflammatory Arthritis	8
Guideline Development and Implementation in Rheumatic Disease	7
Charles L Christian	7
Daniel J McCarty, MD: A Giant of Rheumatology	7
Contributors	7
Chronic Nonbacterial Osteomyelitis	7
A Guide to Contemporary Clinical Practice Guidelines	7
Preventative Care in Scleroderma	7
Cardiac MRI in Rheumatic Disease	7
Imaging of Pulmonary Manifestations of Connective Tissue Disease	6
The Giants of Rheumatology at Johns Hopkins: Lawrence E Shulman, MD, PhD and Mary Betty Stevens, MD	6
E Carwile LeRoy, MD	6
Contributors	6
Contents	6
Copyright	6
The Challenges of New Biologic Therapies in Pediatrics	6
Heart Failure in Rheumatic Disease	6
Imaging of the Major Salivary Glands in Rheumatic Disease	6
Antinuclear Antibody Testing for the Diagnosis of Systemic Lupus Erythematosus	6
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases	5
Therapeutic Advances in Eosinophilic Granulomatosis with Polyangiitis	5
Contributors	5
The Power of Systems Biology	5
The Impact of Pediatric Rheumatic Diseases on Sexual Health, Family Planning, and Pregnancy	5
Environmental Triggers for Rheumatic Disease: From “Why Did I Get This?” to “How Can We Prevent This?”	5
Beyond Coronary Artery Disease	5
Copyright	5
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases	5
The Role of Psychology in Pediatric Rheumatic Diseases	5
Forthcoming Issues	5
Biomarkers in Childhood-Onset Systemic Lupus Erythematosus	5

Copyright	4
Recommendations for the Use of Nonsteroidal Anti-inflammatory Drugs and Cardiovascular Disease Risk	4
Treatment Guidelines in Gout	4
CARRA	4
Management and Cure of Gouty Arthritis	4
Health Care Utilization	4
SARS-CoV-2 Infection and COVID-19 in Children	4
Environmental Risk Factors for Osteoarthritis: The Impact on Individuals with Knee Joint Injury	4
Patient Engagement in Pediatric Rheumatology Research	4
Contents	4
Pediatric Rheumatic Disease in Lower to Middle-Income Countries	4
Dual-Energy Computed Tomography Applications in Rheumatology	4
Treatment Guidelines in Pediatric Rheumatic Diseases	4
Genetic Defects in Early-Onset Inflammatory Bowel Disease	4
Updates in Systemic Sclerosis Treatment and Applicability to Pediatric Scleroderma	4
Role of Environment in Pediatric Rheumatic Diseases	4
Pediatric Rheumatology Comes of Age: Part I	4
Cardiovascular Health in Pediatric Rheumatologic Diseases	4